Ownership

Mary Ann Gray

Insider Reports History

Entity: Individual
Location: 201 W 70 Th St, Suite 23 K, New York, NY
Signature: /s/ Neil Lerner, as attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mary Ann Gray:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Sarepta Therapeutics, Inc.	Director	Common Stock	12.4K	$993K	$80.34	Mar 7, 2022	Direct
RAPT Therapeutics, Inc.	Director	Stock Option (right to buy)	36.5K	$277K	$7.58	May 22, 2024	Direct
BioAtla, Inc.	Director	Common Stock	53.9K	$81.4K	$1.51	Jun 13, 2024	Direct
PALISADE BIO, INC.	Director	Restricted Stock Units	5.82K	$2.97K	$0.51	Nov 21, 2023	Direct
Compass Therapeutics, Inc.	Director	Stock Option (Right to Buy)	40K			Feb 11, 2025	Direct
Keros Therapeutics, Inc.	Director	Stock Option (right to buy)	10K			May 30, 2024	Direct
PALISADE BIO, INC.	Director	Common Stock Options	6.88K			Nov 21, 2023	Direct
Sarepta Therapeutics, Inc.	Director	Stock Option (right to buy)	5.08K			Mar 7, 2022	Direct

Previous1Next

Showing 1 to 8 of 8 entries

Insider Reports Filed by Mary Ann Gray

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
CMPX	Compass Therapeutics, Inc.	Feb 11, 2025	1	$0	4	Feb 13, 2025	Director
BCAB	BioAtla, Inc.	Jun 13, 2024	1	$0	4	Jun 14, 2024	Director
KROS	Keros Therapeutics, Inc.	May 30, 2024	1	$0	4	Jun 3, 2024	Director
RAPT	RAPT Therapeutics, Inc.	May 22, 2024	1	$0	4	May 23, 2024	Director
RAPT	RAPT Therapeutics, Inc.	Mar 28, 2024	1	$65K	4	Apr 1, 2024	Director
CMPX	Compass Therapeutics, Inc.	Feb 9, 2024	1	$0	4	Feb 14, 2024	Director
BCAB	BioAtla, Inc.	Dec 31, 2023	1	$0	4	Jan 3, 2024	Director
PALI	PALISADE BIO, INC.	Nov 21, 2023	2	$0	4	Nov 24, 2023	Director
BCAB	BioAtla, Inc.	Sep 30, 2023	1	$0	4	Oct 3, 2023	Director
BCAB	BioAtla, Inc.	Jun 30, 2023	1	$0	4	Jul 5, 2023	Director
BCAB	BioAtla, Inc.	Jun 14, 2023	1	$0	4	Jun 15, 2023	Director
PALI	PALISADE BIO, INC.	Jun 11, 2023	2	$0	4	Jun 13, 2023	Director
KROS	Keros Therapeutics, Inc.	Jun 6, 2023	1	$0	4	Jun 8, 2023	Director
RAPT	RAPT Therapeutics, Inc.	May 24, 2023	1	$0	4	May 25, 2023	Director
BCAB	BioAtla, Inc.	Mar 31, 2023	1	$0	4	May 15, 2023	Director
RAPT	RAPT Therapeutics, Inc.	Mar 31, 2023	1	$65K	4	Apr 10, 2023	Director
CMPX	Compass Therapeutics, Inc.	Feb 8, 2023	1	$0	4	Feb 9, 2023	Director
BCAB	BioAtla, Inc.	Jun 16, 2022	1	$0	4	Jun 17, 2022	Director
KROS	Keros Therapeutics, Inc.	Jun 1, 2022	1	$0	4	Jun 3, 2022	Director
RAPT	RAPT Therapeutics, Inc.	May 25, 2022	1	$0	4	May 26, 2022	Director
CMPX	Compass Therapeutics, Inc.	Apr 26, 2022	1	$0	4	Apr 28, 2022	Director
CMPX	Compass Therapeutics, Inc.	Apr 26, 2022	0	$0	3	Apr 28, 2022	Director
RAPT	RAPT Therapeutics, Inc.	Mar 31, 2022	1	$65K	4	Apr 4, 2022	Director
SRPT	Sarepta Therapeutics, Inc.	Mar 7, 2022	2	$0	4	Mar 8, 2022	Director
SRPT	Sarepta Therapeutics, Inc.	Dec 10, 2021	2	$0	4	Dec 14, 2021	Director
PALI	PALISADE BIO, INC.	Nov 18, 2021	1	$0	4	Feb 10, 2022	Director
BCAB	BioAtla, Inc.	Jun 15, 2021	1	$0	4	Jun 16, 2021	Director
KROS	Keros Therapeutics, Inc.	Jun 1, 2021	1	$0	4	Jun 3, 2021	Director
RAPT	RAPT Therapeutics, Inc.	May 28, 2021	1	$0	4	Jun 24, 2021	Director